Baxion
Screening
Tags
Alerts
Theme
Lisata Therapeutics, Inc.
LSTA
·
NASDAQ
·
$3.20
Share Price as of 11/2
·
$29M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/11/26
10-K/A
FY 2025
04/28/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/06/25
Disclosures
Filter
8-K
Current report
10/14/26
8-K
Current report
09/17/26
8-K
Current report
08/04/26
8-K
Current report
07/24/26
8-K
Current report
07/17/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
01/08/26
424B5
Prospectus supplement
08/21/24
S-8
Registration of securities for employees
07/15/24
S-3
Shelf registration
05/01/24
S-8
Registration of securities for employees
07/13/23
Proxies
Filter
DEF 14A
Definitive proxy
10/19/26
PRE 14A
Preliminary proxy
10/07/26
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
DEF 14A
Definitive proxy
04/29/24
Ownership
Filter
Form 3
Initial insider ownership
10/15/26
Form 3
Initial insider ownership
09/28/26
Form 3
Initial insider ownership
09/28/26
SC 13G
Beneficial ownership
08/26/26
Form 4
Insider transaction
01/13/26
Other
Filter
ARS
Annual report to shareholders
10/19/26
D
D
10/02/26
SC TO-T/A
SC TO-T/A
07/28/26
SC 14D9/A
Solicitation/Recommendation (amended)
07/21/26
SC 14D9/A
Solicitation/Recommendation (amended)
07/17/26
Latest Filings
Filter
DEF 14A
Definitive proxy
10/19/26
ARS
Annual report to shareholders
10/19/26
8-K
Current report
10/14/26
PRE 14A
Preliminary proxy
10/07/26
D
D
10/02/26
Ownership
Filter
Form 3
Initial insider ownership
10/15/26
Form 3
Initial insider ownership
09/28/26
Form 3
Initial insider ownership
09/28/26
SC 13G
Beneficial ownership
08/26/26
Form 4
Insider transaction
01/13/26